Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating cell therapies into cures for difficult-to-treat cancers and autoimmune diseases in the United States. The company develops MB-106, a CD20-targeted chimeric antigen receptor (CAR) T cell therapy which is in Phase I... Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating cell therapies into cures for difficult-to-treat cancers and autoimmune diseases in the United States. The company develops MB-106, a CD20-targeted chimeric antigen receptor (CAR) T cell therapy which is in Phase I clinical trail for non-hodgkin lymphoma, chronic lymphocytic leukemia, and autoimmune diseases; MB-109, a combination MB-101 and MB-108 as a potential treatment for IL13Ra2+ relapsed or refractory glioblastoma and high-grade astrocytoma; MB-101, an IL13Ra2 CAR T cell program completd Phase I for glioblastoma; and MB-108 which is in Phase I for the treatment of herpes simplex virus-1 oncolytic virus C134. It has a license agreement with city of hope national medical center and nationwide children’s hospital. Mustang Bio, Inc. was incorporated in 2015 and is headquartered in Waltham, Massachusetts. 詳細を表示
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.012 | 1.76366843034 | 0.6804 | 0.848 | 0.6701 | 80828 | 0.7500229 | CS |
| 4 | 0.0984 | 16.5656565657 | 0.594 | 0.848 | 0.594 | 313969 | 0.68075124 | CS |
| 12 | -0.1175 | -14.5079639462 | 0.8099 | 0.848 | 0.5802 | 129322 | 0.69004315 | CS |
| 26 | -0.4476 | -39.2631578947 | 1.14 | 1.2 | 0.5306 | 152376 | 0.76115991 | CS |
| 52 | -0.4976 | -41.8151260504 | 1.19 | 7 | 0.5306 | 1545068 | 2.98421503 | CS |
| 156 | -6.7876 | -90.743315508 | 7.48 | 8.17 | 0.1066 | 3869288 | 0.91644685 | CS |
| 260 | -2.8476 | -80.4406779661 | 3.54 | 8.17 | 0.1066 | 2618517 | 0.99630502 | CS |
makinezmoney
11月前
mining101
1年前
tw0122
1年前
tw0122
1年前
tw0122
1年前
zeusgodmd
1年前
zeusgodmd
1年前
zeusgodmd
1年前
Invest-in-America
1年前
Invest-in-America
1年前
Invest-in-America
1年前
Invest-in-America
1年前
Invest-in-America
1年前
Invest-in-America
1年前
Invest-in-America
1年前
Invest-in-America
1年前
Invest-in-America
1年前
Invest-in-America
1年前
Invest-in-America
1年前
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。